Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
April 07, 2017Ghassan Abou-Alfa, MD, MBA: Debate: Is there a standard second line therapy for HCC? - Regorafenib is a winnerWebcast: Great Debates and Updates in GI Malignancies 201712 minPlay
April 07, 2017Tanios S. Bekaii-Saab, MD: Debate: Is there a standard second line therapy for HCC? - No standard of therapyWebcast: Great Debates and Updates in GI Malignancies 20179 minPlay
April 07, 2017Ghassan Abou-Alfa, MD, MBA: Update: Novel treatments for HCC in the era of hepatitis C therapiesWebcast: Great Debates and Updates in GI Malignancies 201722 minPlay
April 07, 2017Scott Kopetz, MD, PhD, FACP: Update: Novel therapies beyond immunotherapy in GI CancersWebcast: Great Debates and Updates in GI Malignancies 201728 minPlay
April 07, 2017Zsofia K. Stadler, MD: Update: Hereditary syndromes in GI cancer: Who should be tested and why?Webcast: Great Debates and Updates in GI Malignancies 201723 minPlay
April 07, 2017Scott Kopetz, MD, PhD, FACP: Update: Advances in liquid biopsiesWebcast: Great Debates and Updates in GI Malignancies 201731 minPlay
April 07, 2017Jonathan Strosberg, MD: Updates in the management of neuroendocrine cancersWebcast: Great Debates and Updates in GI Malignancies 201731 minPlay
April 07, 2017Michael A. Choti, MD: Debate: Is there a role for surgical management of metastatic neuroendocrine cancer? - YesWebcast: Great Debates and Updates in GI Malignancies 201715 minPlay
April 07, 2017Jonathan Strosberg, MD: Debate: Is there a role for surgical management of metastatic neuroendocrine cancer? - NoWebcast: Great Debates and Updates in GI Malignancies 20179 minPlay
April 07, 2017David H. Ilson, MD, PhD: Debate: Does radiation therapy play a role in gastric cancer adjuvant therapy? - NoWebcast: Great Debates and Updates in GI Malignancies 201712 minPlay